Pharmacodynamics News and Research

RSS
Taking blood pressure pills at bedtime best for heart

Taking blood pressure pills at bedtime best for heart

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

Research provides new options for treatment of multi-drug resistant infections

Research provides new options for treatment of multi-drug resistant infections

Alcohol, Cannabis and Other Drugs: A Pharmacological Evaluation

Alcohol, Cannabis and Other Drugs: A Pharmacological Evaluation

Successful testing of multi-organ "human-on-a-chip" could replace animals as test subjects

Successful testing of multi-organ "human-on-a-chip" could replace animals as test subjects

£500,000 grant could pave way for new antibiotic to battle against drug-resistant superbugs

£500,000 grant could pave way for new antibiotic to battle against drug-resistant superbugs

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Experts describe role of quantitative systems pharmacology in first-in-human clinical trials

Experts describe role of quantitative systems pharmacology in first-in-human clinical trials

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

New antifungal drug developed to help in treatment of invasive fungal infections

New antifungal drug developed to help in treatment of invasive fungal infections

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

Study finds link between upper GI infections and protein implicated in Parkinson’s disease

Study finds link between upper GI infections and protein implicated in Parkinson’s disease

Antibiotic resistance: a healthcare emergency?

Antibiotic resistance: a healthcare emergency?

New position paper recommends sex-specific cardiovascular drug dosages for better treatment

New position paper recommends sex-specific cardiovascular drug dosages for better treatment